Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
2020 · Cell · 563 citations
https://doi.org/10.1016/j.cell.2020.10.043
A
Anne Palser
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
3.4K
Citations
21
h-index
26
i10-index
Anne Palser is an academic researcher from Biotechnology Research Center. The author has contributed to research in topics: Viral-associated cancers and disorders & SARS-CoV-2 and COVID-19 Research & Lymphoma Diagnosis and Treatment. The author has an h-index of 21, co-authored 35 publications.
ORCID: 0000-0002-9476-8808Papers by this author
worksDynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones
2016 · Experimental Hematology · 13 citations
https://doi.org/10.1016/j.exphem.2016.09.010
Human immunodeficiency virus Tat associates with a specific set of cellular RNAs
2014 · Retrovirology · 12 citations
https://doi.org/10.1186/1742-4690-11-53
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
2024 · npj Vaccines · 11 citations
https://doi.org/10.1038/s41541-024-00982-1
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
2025 · Cell Reports · 3 citations
https://doi.org/10.1016/j.celrep.2025.115499
Fig S1 from Essential role of inverted repeat in Epstein–Barr virus IR-1 in B cell transformation; geographical variation of the viral genome
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7825739
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat